Teva Pharmaceuticals in Deal With Texas Settling Opioid-Related Claims
07 Février 2022 - 5:01PM
Dow Jones News
By Chris Wack
Teva Pharmaceutical Industries Ltd. said its Teva
Pharmaceuticals affiliate has reached an agreement with the
attorney general of Texas that settles the state's and its
subdivisions opioid-related claims.
Under the terms of the settlement, Teva will pay Texas $150
million over a 15-year time period, and will provide the recently
launched generic Narcan naloxone hydrochloride nasal spray, valued
at $75 million over 10 years.
Naloxone is a medication that can reverse an overdose from
opioids.
The company said it will continue to defend itself in court in
states where it hasn't reached terms of a settlement agreement.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
February 07, 2022 10:46 ET (15:46 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
